tiprankstipranks
Trending News
More News >
Cytek Biosciences, Inc. (CTKB)
:CTKB
US Market

Cytek Biosciences (CTKB) Income Statement

Compare
55 Followers

Cytek Biosciences Income Statement

Last quarter (Q4 2024), Cytek Biosciences's total revenue was $33.65M, a decrease of -42.21% from the same quarter last year. In Q4, Cytek Biosciences's net income was $9.64M. See Cytek Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 200.45M$ 193.01M$ 164.04M$ 127.95M$ 92.84M
Gross Profit
$ 111.11M$ 109.43M$ 100.97M$ 79.14M$ 51.71M
Operating Expenses
$ 131.63M$ 137.27M$ 102.78M$ 69.98M$ 38.05M
Depreciation and Amortization
$ 0.00$ 9.23M$ 5.70M$ 1.24M$ 603.00K
EBITDA
$ -20.52M$ -4.41M$ 9.54M$ 10.40M$ 15.37M
Operating Income
$ -20.52M$ -27.84M$ -1.83M$ 6.45M$ 13.66M
Other Income/Expenses
$ 14.82M$ 12.14M$ 3.06M$ -3.22M$ 771.00K
Pretax Income
$ -5.70M$ -15.71M$ 1.26M$ 5.95M$ 14.43M
Net Income
$ -6.02M$ -12.15M$ 2.58M$ 4.42M$ 19.41M
Per Share Metrics
Basic EPS
$ 0.00$ -0.09$ 0.02$ 0.03$ 0.02
Diluted EPS
$ 0.00$ -0.09$ 0.02$ 0.03$ 0.02
Weighted Average Shares Outstanding
131.00M 135.28M 134.51M 133.75M 132.99M
Weighted Average Shares Outstanding (Diluted)
132.79M 135.28M 138.56M 133.75M 132.99M
Currency in USD

Cytek Biosciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis